SEC Tracker
Get the app

Biovie BIVI

Biovie: quarterly report for the quarter ended Dec 31, 2022

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q
Exhibit 10.1
Material contract

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Biovie files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. GT Biopharma GTBP public float $9M, Jun 30, 2025
  2. Talphera TLPH public float $8M, Jun 30, 2025
  3. Processa Pharmaceuticals PCSA public float $8M, Jun 30, 2025
  4. TherapeuticsMD TXMD public float $9M, Jun 30, 2025
  5. Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025